Cardiometabolic risk factors in Children with Celiac Disease on a gluten-free diet

Short Communication - Current Pediatric Research (2020) Volume 0, Issue 0

Celiac disease (CD) is an immune-mediated systemic condition evoked by gluten and related prolamines in genetically predisposed

subjects, characterized by a variable combination of clinical symptoms, CD-specific antibodies, HLA-DQ2 and HLA-DQ8 haplotypes,

and enteropathy. The only therapy is a life-long gluten free diet (GFD). Strict GFD adherence results in full clinical, serological and

histological remission, avoiding long-term complications in CD patients. However, gluten-free products have high levels of lipids,

sugar and salt to improve food palatability and consistency, and subjects with CD show an excessive consumption of hypercaloric

and hyperlipidic foods to compensate dietetic restriction. GFD may therefore have a negative impact on cardiometabolic risk factors

such as obesity, serum lipid levels, insulin resistance, metabolic syndrome, and atherosclerosis. We analysed the current clinical

evidence on the impact of GFD on cardiometabolic risk factors in children and adolescents with CD. The available literature shows

conflicting data: the majority of studies indicate changes in markers associated with cardiovascular risk. However, these variations do

not constantly point at a better or worse cardiovascular risk profile. Limitations of most studies comprise the relatively small sample

size, the cross-¬sectional design that does not permit comparison between pre-¬ and post¬-GFD values of the evaluated parameters,

and the absence of knowledge of familial history for CVD risk factors. Therefore, additional longitudinal, well¬ designed studies

involving a large number of children with long-¬term follow¬-up are necessary to clarify whether prolonged exposure to GFD

might result in an increased cardiometabolic risk. GFD remains the milestone of CD treatment. Nonetheless, an in-depth assessment

of nutritional status along with cardiometabolic screening in CD children at diagnosis and during GFD have to be recommended

because an early intervention may prevent cardiovascular morbidity. Dietary guidance over time, besides monitoring adherence to

GFD, may therefore be warranted in youths with CD.

Author(s): Francesca Olivero